COVER STORY - Webfactory

Local biotech companies may not place their IP in a US holding company in which they hold shares. The alternative is to sell the company outright. Sherwin says deals are also lost because a listed US firm cannot buy a small SA biotech company for a portion of cash and equity. Exchange controls prohibit an SA company from holding offshore equity ... ................
................